학술논문

Pre-clinical evaluation of the PP2A inhibitor LB-100 for the treatment of lapatinib resistant HER2-positive breast cancer.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2018, 36 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755